Discover
IDXX
IDEXX Laboratories, Inc.
590.54
1 x 590.37
1 x 591.00
bid
ask
-
5.22
0.88%
01:41 PM
timesize
| Ytd | -12.71% | |
| 1y | -9.44% |
587.04
day range
597.99
526.44
52 week range
766.68
| Open | 595.24 | Prev Close | 595.76 | Low | 587.04 | High | 597.99 | Mkt Cap | 46.59B |
| Vol | 207.11K | Avg Vol | 668.11K | EPS | 14.22 | P/E | 41.53 | Forward P/E | 35.15 |
| Beta | 1.54 | Short Ratio | 2.84 | Inst. Own | 96.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 560.52 | 200-d Avg | 618.92 | 1yr Est | 705.85 |
| Income Statement | |||
| Total Revenue | 1.22B | ||
| Revenues (USD) | 1.22B | ||
| Cost of Revenue | 437.50M | ||
| Gross Profit | 779.09M | ||
| Operating Expenses | 353.52M | ||
| Research and Development Expense | 65.43M | ||
| Selling, General and Administrative Expense | 288.09M | ||
| Operating Income | 425.57M | ||
| Interest Expense | 10.18M | ||
| Income Tax Expense | 78.81M | ||
| Net Income | 338.41M | ||
| Net Income Common Stock | 338.41M | ||
| Net Income Common Stock (USD) | 338.41M | ||
| Consolidated Income | 338.41M | ||
| Earnings per Basic Share | 4.29 | ||
| Earnings per Basic Share (USD) | 4.29 | ||
| Earnings per Diluted Share | 4.27 | ||
| Earning Before Interest & Taxes (EBIT) | 427.41M | ||
| Earning Before Interest & Taxes (USD) | 427.41M | ||
| Weighted Average Shares | 78.95M | ||
| Weighted Average Shares Diluted | 79.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 196.93M | ||
| Cash and Equivalents (USD) | 196.93M | ||
| Trade and Non-Trade Receivables | 627.08M | ||
| Current Assets | 1.51B | ||
| Property, Plant & Equipment Net | 856.00M | ||
| Total Assets | 3.44B | ||
| Debt Current | 669.00M | ||
| Total Debt | 1.07B | ||
| Current Liabilities | 1.29B | ||
| Debt Non-Current | 400.37M | ||
| Total Liabilities | 1.83B | ||
| Accumulated Retained Earnings (Deficit) | 7.01B | ||
| Accumulated Other Comprehensive Income | -63.54M | ||
| Shareholders Equity | 1.61B | ||
| Shareholders Equity (USD) | 1.61B | ||
| Assets Non-Current | 1.93B | ||
| Total Debt (USD) | 1.07B | ||
| Deferred Revenue | 68.99M | ||
| Goodwill and Intangible Assets | 509.12M | ||
| Inventory | 391.58M | ||
| Liabilities Non-Current | 542.10M | ||
| Trade and Non-Trade Payables | 129.10M | ||
| Tax Liabilities | 52.64M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 41.05M | ||
| Net Cash Flow from Financing | -325.19M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.59M | ||
| Capital Expenditure | -24.65M | ||
| Issuance (Purchase) of Equity Shares | -313.89M | ||
| Issuance (Repayment) of Debt Securities | -11.00M | ||
| Net Cash Flow from Investing | -25.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1.04M | ||
| Net Cash Flow from Operations | 347.16M | ||
| Effect of Exchange Rate Changes on Cash | -72.00K | ||
| Share Based Compensation | 16.09M | ||